OK432 (Picibanil) in the Treatment of Lymphatic Malformations

Clinical trial NCT03427619 · COMPLETED

Trial details

NCT number: NCT03427619
Sponsor: Richard JH Smith
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphatic Malformations

Start date: 2005-10-05
Primary completion: 2018-04-30
Enrollment: 275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.